Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global Anti Obesity Drugs Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 Novo Nordisk
  • 5.1.1 Novo Nordisk Company Profile
  • 5.1.2 Novo Nordisk Business Overview
  • 5.1.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 Novo Nordisk Anti Obesity Drugs Products Introduction
• 5.2 Pfizer
  • 5.2.1 Pfizer Company Profile
  • 5.2.2 Pfizer Business Overview
  • 5.2.3 Pfizer Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 Pfizer Anti Obesity Drugs Products Introduction
• 5.3 Bayer AG
  • 5.3.1 Bayer AG Company Profile
  • 5.3.2 Bayer AG Business Overview
  • 5.3.3 Bayer AG Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 Bayer AG Anti Obesity Drugs Products Introduction
• 5.4 F Hoffmann-La Roche
  • 5.4.1 F Hoffmann-La Roche Company Profile
  • 5.4.2 F Hoffmann-La Roche Business Overview
  • 5.4.3 F Hoffmann-La Roche Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 F Hoffmann-La Roche Anti Obesity Drugs Products Introduction
• 5.5 GlaxoSmithKline
  • 5.5.1 GlaxoSmithKline Company Profile
  • 5.5.2 GlaxoSmithKline Business Overview
  • 5.5.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 GlaxoSmithKline Anti Obesity Drugs Products Introduction
• 5.6 Vivus
  • 5.6.1 Vivus Company Profile
  • 5.6.2 Vivus Business Overview
  • 5.6.3 Vivus Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 Vivus Anti Obesity Drugs Products Introduction
• 5.7 Currax Pharmaceuticals
  • 5.7.1 Currax Pharmaceuticals Company Profile
  • 5.7.2 Currax Pharmaceuticals Business Overview
  • 5.7.3 Currax Pharmaceuticals Anti Obesity Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.7.4 Currax Pharmaceuticals Anti Obesity Drugs Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global Anti Obesity Drugs Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global Anti Obesity Drugs Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global Anti Obesity Drugs Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global Anti Obesity Drugs Price by Types (2015-2020)
• 6.2 Global Anti Obesity Drugs Market Forecast by Types (2020-2025)
  • 6.2.1 Global Anti Obesity Drugs Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global Anti Obesity Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global Anti Obesity Drugs Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global Anti Obesity Drugs Sales, Price and Growth Rate of Peripherally Acting Anti-obesity Drugs
  • 6.3.2 Global Anti Obesity Drugs Sales, Price and Growth Rate of Centrally Acting Anti-obesity Drugs
• 6.4 Global Anti Obesity Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 Peripherally Acting Anti-obesity Drugs Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Centrally Acting Anti-obesity Drugs Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global Anti Obesity Drugs Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global Anti Obesity Drugs Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global Anti Obesity Drugs Revenue and Market Share by Applications (2015-2020)
• 7.2 Global Anti Obesity Drugs Market Forecast by Applications (2020-2025)
  • 7.2.1 Global Anti Obesity Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global Anti Obesity Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global Anti Obesity Drugs Revenue, Sales and Growth Rate of Prescription Drugs (2015-2020)
  • 7.3.2 Global Anti Obesity Drugs Revenue, Sales and Growth Rate of OTC drugs (2015-2020)
• 7.4 Global Anti Obesity Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Prescription Drugs Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 OTC drugs Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global Anti Obesity Drugs Sales by Regions (2015-2020)
• 8.2 Global Anti Obesity Drugs Market Revenue by Regions (2015-2020)
• 8.3 Global Anti Obesity Drugs Market Forecast by Regions (2020-2025)

9 North America Anti Obesity Drugs Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)
• 9.3 North America Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)
• 9.4 North America Anti Obesity Drugs Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America Anti Obesity Drugs Market Analysis by Country
  • 9.6.1 U.S. Anti Obesity Drugs Sales and Growth Rate
  • 9.6.2 Canada Anti Obesity Drugs Sales and Growth Rate
  • 9.6.3 Mexico Anti Obesity Drugs Sales and Growth Rate

10 Europe Anti Obesity Drugs Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)
• 10.3 Europe Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe Anti Obesity Drugs Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe Anti Obesity Drugs Market Analysis by Country
  • 10.6.1 Germany Anti Obesity Drugs Sales and Growth Rate
  • 10.6.2 United Kingdom Anti Obesity Drugs Sales and Growth Rate
  • 10.6.3 France Anti Obesity Drugs Sales and Growth Rate
  • 10.6.4 Italy Anti Obesity Drugs Sales and Growth Rate
  • 10.6.5 Spain Anti Obesity Drugs Sales and Growth Rate
  • 10.6.6 Russia Anti Obesity Drugs Sales and Growth Rate

11 Asia-Pacific Anti Obesity Drugs Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific Anti Obesity Drugs Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific Anti Obesity Drugs Market Analysis by Country
  • 11.6.1 China Anti Obesity Drugs Sales and Growth Rate
  • 11.6.2 Japan Anti Obesity Drugs Sales and Growth Rate
  • 11.6.3 South Korea Anti Obesity Drugs Sales and Growth Rate
  • 11.6.4 Australia Anti Obesity Drugs Sales and Growth Rate
  • 11.6.5 India Anti Obesity Drugs Sales and Growth Rate

12 South America Anti Obesity Drugs Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)
• 12.3 South America Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)
• 12.4 South America Anti Obesity Drugs Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America Anti Obesity Drugs Market Analysis by Country
  • 12.6.1 Brazil Anti Obesity Drugs Sales and Growth Rate
  • 12.6.2 Argentina Anti Obesity Drugs Sales and Growth Rate
  • 12.6.3 Columbia Anti Obesity Drugs Sales and Growth Rate

13 Middle East and Africa Anti Obesity Drugs Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa Anti Obesity Drugs Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa Anti Obesity Drugs Market Analysis by Country
  • 13.6.1 UAE Anti Obesity Drugs Sales and Growth Rate
  • 13.6.2 Egypt Anti Obesity Drugs Sales and Growth Rate
  • 13.6.3 South Africa Anti Obesity Drugs Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Anti Obesity Drugs Market Size and Growth Rate 2015-2025

Table Anti Obesity Drugs Key Market Segments

Figure Global Anti Obesity Drugs Market Revenue ($) Segment by Type from 2015-2020

Figure Global Anti Obesity Drugs Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Anti Obesity Drugs

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Novo Nordisk Company Profile

Table Novo Nordisk Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Novo Nordisk Production and Growth Rate

Figure Novo Nordisk Market Revenue ($) Market Share 2015-2020

Table Pfizer Company Profile

Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Pfizer Production and Growth Rate

Figure Pfizer Market Revenue ($) Market Share 2015-2020

Table Bayer AG Company Profile

Table Bayer AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bayer AG Production and Growth Rate

Figure Bayer AG Market Revenue ($) Market Share 2015-2020

Table F Hoffmann-La Roche Company Profile

Table F Hoffmann-La Roche Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure F Hoffmann-La Roche Production and Growth Rate

Figure F Hoffmann-La Roche Market Revenue ($) Market Share 2015-2020

Table GlaxoSmithKline Company Profile

Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure GlaxoSmithKline Production and Growth Rate

Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020

Table Vivus Company Profile

Table Vivus Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Vivus Production and Growth Rate

Figure Vivus Market Revenue ($) Market Share 2015-2020

Table Currax Pharmaceuticals Company Profile

Table Currax Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Currax Pharmaceuticals Production and Growth Rate

Figure Currax Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Global Anti Obesity Drugs Sales by Types (2015-2020)

Table Global Anti Obesity Drugs Sales Share by Types (2015-2020)

Table Global Anti Obesity Drugs Revenue ($) by Types (2015-2020)

Table Global Anti Obesity Drugs Revenue Share by Types (2015-2020)

Table Global Anti Obesity Drugs Price ($) by Types (2015-2020)

Table Global Anti Obesity Drugs Market Forecast Sales by Types (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Sales Share by Types (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Revenue ($) by Types (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Revenue Share by Types (2020-2025)

Figure Global Peripherally Acting Anti-obesity Drugs Sales and Growth Rate (2015-2020)

Figure Global Peripherally Acting Anti-obesity Drugs Price (2015-2020)

Figure Global Centrally Acting Anti-obesity Drugs Sales and Growth Rate (2015-2020)

Figure Global Centrally Acting Anti-obesity Drugs Price (2015-2020)

Figure Global Anti Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Peripherally Acting Anti-obesity Drugs (2020-2025)

Figure Global Anti Obesity Drugs Sales and Growth Rate Forecast of Peripherally Acting Anti-obesity Drugs (2020-2025)

Figure Global Anti Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Centrally Acting Anti-obesity Drugs (2020-2025)

Figure Global Anti Obesity Drugs Sales and Growth Rate Forecast of Centrally Acting Anti-obesity Drugs (2020-2025)

Table Global Anti Obesity Drugs Sales by Applications (2015-2020)

Table Global Anti Obesity Drugs Sales Share by Applications (2015-2020)

Table Global Anti Obesity Drugs Revenue ($) by Applications (2015-2020)

Table Global Anti Obesity Drugs Revenue Share by Applications (2015-2020)

Table Global Anti Obesity Drugs Market Forecast Sales by Applications (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Sales Share by Applications (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Prescription Drugs Sales and Growth Rate (2015-2020)

Figure Global Prescription Drugs Price (2015-2020)

Figure Global OTC drugs Sales and Growth Rate (2015-2020)

Figure Global OTC drugs Price (2015-2020)

Figure Global Anti Obesity Drugs Market Revenue ($) and Growth Rate Forecast of Prescription Drugs (2020-2025)

Figure Global Anti Obesity Drugs Sales and Growth Rate Forecast of Prescription Drugs (2020-2025)

Figure Global Anti Obesity Drugs Market Revenue ($) and Growth Rate Forecast of OTC drugs (2020-2025)

Figure Global Anti Obesity Drugs Sales and Growth Rate Forecast of OTC drugs (2020-2025)

Figure Global Anti Obesity Drugs Sales and Growth Rate (2015-2020)

Table Global Anti Obesity Drugs Sales by Regions (2015-2020)

Table Global Anti Obesity Drugs Sales Market Share by Regions (2015-2020)

Figure Global Anti Obesity Drugs Sales Market Share by Regions in 2019

Figure Global Anti Obesity Drugs Revenue and Growth Rate (2015-2020)

Table Global Anti Obesity Drugs Revenue by Regions (2015-2020)

Table Global Anti Obesity Drugs Revenue Market Share by Regions (2015-2020)

Figure Global Anti Obesity Drugs Revenue Market Share by Regions in 2019

Table Global Anti Obesity Drugs Market Forecast Sales by Regions (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Sales Share by Regions (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Anti Obesity Drugs Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure North America Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)

Figure North America Anti Obesity Drugs Market Forecast Sales (2020-2025)

Figure North America Anti Obesity Drugs Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Canada Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Mexico Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Europe Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Europe Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)

Figure Europe Anti Obesity Drugs Market Forecast Sales (2020-2025)

Figure Europe Anti Obesity Drugs Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure France Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Italy Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Spain Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Russia Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Anti Obesity Drugs Market Forecast Sales (2020-2025)

Figure Asia-Pacific Anti Obesity Drugs Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Japan Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure South Korea Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Australia Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure India Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure South America Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure South America Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)

Figure South America Anti Obesity Drugs Market Forecast Sales (2020-2025)

Figure South America Anti Obesity Drugs Market Forecast Revenue ($) (2020-2025)

Figure Brazil Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Argentina Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Columbia Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Anti Obesity Drugs Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Anti Obesity Drugs Market Forecast Sales (2020-2025)

Figure Middle East and Africa Anti Obesity Drugs Market Forecast Revenue ($) (2020-2025)

Figure UAE Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure Egypt Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Figure South Africa Anti Obesity Drugs Market Sales and Growth Rate (2015-2020)

Based on the Anti Obesity Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Anti Obesity Drugs market covered in Chapter 5:
Novo Nordisk
Pfizer
Bayer AG
F Hoffmann-La Roche
GlaxoSmithKline
Vivus
Currax Pharmaceuticals

In Chapter 6, on the basis of types, the Anti Obesity Drugs market from 2015 to 2025 is primarily split into:
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs

In Chapter 7, on the basis of applications, the Anti Obesity Drugs market from 2015 to 2025 covers:
Prescription Drugs
OTC drugs

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025